Evolution of Parkinson's disease. Conclusions

被引：0
|
作者：
Garcia-Ruiz, Pedro J. [1 ]
机构：
[1] Fdn Jimenez Diaz, Serv Neurol, Ave Reyes Catolicos 2, E-28040 Madrid, Spain
来源：
REVISTA DE NEUROLOGIA | 2010年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [21] Segregation analysis of Parkinson's disease.
    Zareparsi, S
    Taylor, TD
    Larson, K
    Nutt, J
    Harris, EL
    Payami, H
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A216 - A216
  • [22] Psychosocial aspects of Parkinson's disease.
    Scholz, H
    Barolin, GS
    NEUROPSYCHIATRIE, 1995, 9 : S38 - S39
  • [23] Treatment of Parkinson's disease. Duodopa®
    Valldeoriola, F.
    REVISTA DE NEUROLOGIA, 2010, 50 : S34 - S36
  • [24] Sentence comprehension in Parkinson's disease.
    Grossman, M
    BRAIN AND COGNITION, 1996, 30 (03) : 19 - 19
  • [25] Neuropsychiatric aspects of Parkinson's disease.
    Aarsland D.
    Karlsen K.
    Current Psychiatry Reports, 1999, 1 (1) : 61 - 68
  • [26] Levodopa and the progression of Parkinson's disease.
    Morgan J.
    Sethi K.D.
    Current Neurology and Neuroscience Reports, 2005, 5 (4) : 261 - 262
  • [27] Combined treatment in Parkinson's disease.
    Reisecker, F
    Ladurner, G
    NEUROPSYCHIATRIE, 1995, 9 : S27 - S29
  • [28] Psychiatric symptoms in Parkinson's disease.
    Anderson K.E.
    Weiner W.J.
    Current Neurology and Neuroscience Reports, 2002, 2 (4) : 303 - 309
  • [29] Cell therapy for Parkinson's disease.
    Fischbach, GD
    McKhann, GM
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10): : 763 - 765
  • [30] Levodopa for the Treatment of Parkinson's Disease.
    LeWitt, Peter A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (23): : 2468 - 2476
12345